Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.7 - $1.4 $726 - $1,453
-1,038 Reduced 85.93%
170 $0
Q1 2022

May 12, 2022

SELL
$0.63 - $1.59 $1,789 - $4,517
-2,841 Reduced 70.17%
1,208 $1,000
Q4 2021

Feb 11, 2022

SELL
$1.27 - $2.42 $3,350 - $6,383
-2,638 Reduced 39.45%
4,049 $5,000
Q3 2021

Nov 05, 2021

SELL
$2.15 - $3.82 $8,847 - $15,719
-4,115 Reduced 38.09%
6,687 $14,000
Q2 2021

Aug 06, 2021

BUY
$2.89 - $4.45 $3,670 - $5,651
1,270 Added 13.32%
10,802 $40,000
Q1 2021

May 07, 2021

SELL
$2.9 - $4.09 $1,771 - $2,498
-611 Reduced 6.02%
9,532 $31,000
Q4 2020

Feb 12, 2021

BUY
$3.38 - $5.14 $1,480 - $2,251
438 Added 4.51%
10,143 $34,000
Q3 2020

Nov 06, 2020

BUY
$2.99 - $4.9 $427 - $700
143 Added 1.5%
9,705 $39,000
Q2 2020

Aug 07, 2020

SELL
$2.11 - $3.38 $5,228 - $8,375
-2,478 Reduced 20.58%
9,562 $32,000
Q1 2020

May 08, 2020

BUY
$1.83 - $3.45 $5,696 - $10,739
3,113 Added 34.87%
12,040 $28,000
Q4 2019

Feb 07, 2020

SELL
$3.5 - $10.35 $9,355 - $27,665
-2,673 Reduced 23.04%
8,927 $32,000
Q3 2019

Nov 08, 2019

BUY
$7.03 - $9.7 $7,423 - $10,243
1,056 Added 10.02%
11,600 $96,000
Q2 2019

Aug 09, 2019

BUY
$7.36 - $11.26 $42,032 - $64,305
5,711 Added 118.17%
10,544 $0
Q1 2019

May 10, 2019

SELL
$9.08 - $11.84 $18,532 - $24,165
-2,041 Reduced 29.69%
4,833 $0
Q4 2018

Feb 08, 2019

BUY
$6.39 - $16.99 $4,460 - $11,859
698 Added 11.3%
6,874 $60,000
Q3 2018

Nov 09, 2018

BUY
$16.52 - $24.82 $21,195 - $31,844
1,283 Added 26.22%
6,176 $0
Q2 2018

Aug 10, 2018

BUY
$14.31 - $21.75 $5,995 - $9,113
419 Added 9.37%
4,893 $0
Q1 2018

May 11, 2018

BUY
$16.09 - $23.07 $20,868 - $29,921
1,297 Added 40.82%
4,474 $0
Q4 2017

Feb 09, 2018

BUY
$13.36 - $20.73 $34,856 - $54,084
2,609 Added 459.33%
3,177 $0
Q3 2017

Nov 13, 2017

BUY
$8.75 - $14.07 $4,970 - $7,991
568
568 $0

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.